AGP Executive Report
Last update: 10 hours agoFood Safety & Climate: An EU-funded campaign under HOLiFOOD is set to use influencers to explain how warmer temperatures and extreme weather can raise risks like Salmonella, Campylobacter and crop toxins, with videos launching mid-June across France, Germany, Hungary, Italy and the UK. Rare Disease Treatment: The European Commission has approved lomitapide capsules for children aged 5+ with homozygous familial hypercholesterolaemia (HoFH), adding a new paediatric option alongside diet and lipid-lowering care. Kidney Health & Diabetes Drugs: New trial results presented at the European Renal Congress suggest semaglutide (Ozempic) may improve quality of life for adults with chronic kidney disease and type 2 diabetes, adding “more healthy days” over two years. Neonatal Screening: A German prospective cohort study finds umbilical cord blood glucose is a poor predictor of transitional neonatal hypoglycaemia, warning against relying on single-point checks. EU Seafood Rules: New EU requirements for freezer vessels are expected to affect about 97% of EU-listed Pacific Island-flagged vessels exporting to the EU, after concerns about reaching -18°C in brine. Public Health Preparedness: The UK NHS is urging staff to be ready for possible Ebola cases, focusing on isolation protocols and PPE stock checks amid low-but-real import risk.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
